Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

831 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Ricardo A, Cecilia Q, Bárbara E, Leila C, Berenice S, Cecilia P, Ignacio RJ, Pappolla A, Miguez J, Patrucco L, Cristiano E, Carlos V, Gabriel V, Emanuel S, Andres B, Norma D, Verónica T, Gisela Z, Dario T, Laura SM, Geraldine L, Laura MM, Edgar CC, Pablo L, Judith S, Pablo D, Javier H, Amelia AP, Adriana C, Eugenia BM, Luciana L, Nora FL, Orlando G; RelevarEM investigators. Ricardo A, et al. Among authors: orlando g. Neurol Sci. 2020 Nov;41(11):3369-3371. doi: 10.1007/s10072-020-04709-7. Neurol Sci. 2020. PMID: 32918634
Neuromodulatory Effects Induced by the Association of Moringa oleifera Lam., Tribulus terrestris L., Rhodiola rosea Lam., and Undaria pinnatidifida Extracts in the Hypothalamus.
Chiavaroli A, Di Simone SC, Acquaviva A, Nilofar N, Libero ML, Brunetti L, Recinella L, Leone S, Orlando G, Zengin G, Di Vito M, Menghini L, Ferrante C. Chiavaroli A, et al. Among authors: orlando g. Chem Biodivers. 2024 Mar 25:e202302075. doi: 10.1002/cbdv.202302075. Online ahead of print. Chem Biodivers. 2024. PMID: 38527165
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience.
Meschiari M, Faltoni M, Kaleci S, Tassoni G, Orlando G, Franceschini E, Burastero G, Bedini A, Serio L, Biagioni E, Melegari G, Venturelli C, Sarti M, Bertellini E, Girardis M, Mussini C. Meschiari M, et al. Among authors: orlando g. Int J Antimicrob Agents. 2024 May;63(5):107134. doi: 10.1016/j.ijantimicag.2024.107134. Epub 2024 Mar 5. Int J Antimicrob Agents. 2024. PMID: 38453094
831 results